New Delhi, May 26 -- Shares of Fredun Pharmaceuticals Limited rose around 3% on Tuesday, May 26, after the company announced a 2:1 bonus issue alongside strong financial results for the quarter and financial year ended March 2026.

The company's board, in its meeting held on May 25, 2026, approved the audited Q4 and FY26 financial results and recommended the issuance of bonus shares in the ratio of 2:1. Under the proposal, shareholders and warrant holders will receive two fully paid-up equity shares of face value Rs.10 each for every one existing fully paid-up equity share of Rs.10 each held on the record date, subject to shareholder approval.

"The Board of Directors, at its meeting held on May 25, 2026, wherein the audited financial res...